| Literature DB >> 33364981 |
Arjan P Palstra1, Ana Roque2, Leo Kruijt1, Pauline Jéhannet1, Jaume Pérez-Sánchez3, Ron P Dirks4.
Abstract
A longer on-land rearing period of Gilthead seabream Sparus aurata before transfer to sea-cages would allow the farmer to benefit from exercise-enhanced growth, resilience, and robustness as induced by increasing water flow in the tanks. In this study, the physiological effects of flow-conditioning were investigated by subjecting large groups of experimental fish to minimal flow or to flow regimes inducing swimming exercise at 1 or 2 body length (BL) s-1 for a period of 8 months (February-October) in 1,500 L tanks. Fish representing the three treatment groups were then used for: (1) a stress challenge netting test and plasma cortisol measurement (baseline, peaking, and recovery levels), (2) blood plasma measurements of glucose, triglycerides, lactate, cholesterol, growth hormone (GH), and insulin-like growth factor 1 (IGF1), and (3) heart and muscle gene expression of the GH and IGF1 receptors and the muscle transcriptome by deep RNA sequencing (RNAseq). Fish size after 8 months of flow conditioning was 92 ± 27 g body weight (BW) for fish under minimal flow, 106 ± 24 g BW (+15%) at 1 BL s-1, and 125 ± 27 g BW (+36%) at 2 BL s-1. Flow conditioning at 1 BL s-1 provided optimal conditions for growth and uniformity, but also stress (lowest baseline plasma cortisol), robustness (higher condition factor and larger hearts), and energy mobilization (increased plasma glucose). Although flow enhanced growth linearly with swimming speed, also the percentage of lordotic fish increased with exercise, particularly high for swimming at 2 BL s-1. The absence of important differences in plasma GH and IGF1, and expression levels of their receptors in heart and white skeletal muscle, indicated that other factors may be involved in growth enhancement. RNAseq of the white skeletal muscle showed upregulated expression of genes involved in muscle contraction, muscle development and its molecular regulation, and immune genes that may play a role in the muscle repair mechanism. An exercise regime of swimming at 1 BL s-1 can be considered as optimal for farming robust seabream although the increase of skeletal deformities should be avoided.Entities:
Keywords: RNAseq; aquaculture; growth performance; robustness; stress resilience; vertebral lordosis
Year: 2020 PMID: 33364981 PMCID: PMC7750471 DOI: 10.3389/fphys.2020.610049
Source DB: PubMed Journal: Front Physiol ISSN: 1664-042X Impact factor: 4.566
Primers for each of the target genes used in real-time PCR (RT-PCR) analysis.
| Target genes | Abv. | Accession number | Primer sequences | T° | Reference |
|---|---|---|---|---|---|
| Ribosomal protein S18 | Rps18 | AM490061.1 | FW: GGGTGTTGGCAGACGTTAC | 60 | |
| Growth hormone receptor 1 | GHR1 | AF438176 | FW: ACCTGTCAGCCACCACATGA | 60 | |
| Growth hormone receptor 2 | GHR2 | AY573601 | FW: GAGTGAACCCGGCCTGACAG | 60 | |
| Insulin-like growth factor 1 receptor a | IGF1Ra | KT156846 | FW: AGCATCAAAGACGAACTGG | 55 | |
| Insulin-like growth factor 1 receptor b | IGF1Rb | KT156847 | FW: GCTAATGCGAATGTGTTGG | 55 |
FW, forward; RV, reverse; T°, annealing temperature.
Figure 1Growth performance. Fish size in (A) BL and (B) body weight (BW) over 8 months of flow conditioning (Jan-Sept, monitoring dates and sample size per group – pg. on the x-axis). Light gray: minimal flow. Medium gray: 1 BL s−1. Dark gray: 2 BL s−1. Asterisks indicate overall significant difference between groups for each date with *p < 0.05 and **p < 0.01.
Morphology, biometry, tissue weight indices, hematocrit, plasma metabolites, and growth hormone growth hormone (GH) and insulin-like growth factor 1 (IGF1) levels.
| C | SD | 1 BL s−1 | SD | 2 BL s−1 | SD | ||
|---|---|---|---|---|---|---|---|
| I. | lordosis | 13% | 23% | 48% | |||
| SL (cm) | 18.0 | 2.0 | 18.0 | 1.8 | 18.3 | 1.5 | |
| BW (g) | |||||||
| K | |||||||
| HW (g) | |||||||
| CI | 0.12 | 0.04 | 0.13 | 0.03 | 0.13 | 0.03 | |
| MFW (g) | |||||||
| MFI | |||||||
| II. | SW (g) | 0.11 | 0.05 | 0.08 | 0.02 | 0.11 | 0.03 |
| SI | 0.077 | 0.025 | 0.062 | 0.014 | 0.074 | 0.012 | |
| LW (g) | 1.48 | 0.80 | 1.39 | 0.34 | 1.51 | 0.43 | |
| HSI | 1.03 | 0.29 | 1.06 | 0.23 | 1.03 | 0.16 | |
| IW (g) | 3.70 | 0.98 | 3.63 | 0.54 | 4.12 | 0.79 | |
| II | 2.80 | 0.29 | 2.78 | 0.34 | 2.84 | 0.31 | |
| carcass W (g) | 120 | 36 | 113 | 14 | 131 | 29 | |
| carcass I | 89.4 | 0.8 | 85.5 | 10.4 | 89.8 | 0.9 | |
| Hct % | 38.5 | 5.8 | 40.1 | 4.6 | 36.7 | 3.8 | |
| gluc (mmol L−1) | |||||||
| lact (mmol L−1) | 4.0 | 1.1 | 4.8 | 1.6 | 3.4 | 1.2 | |
| tg (mmol L−1) | 3.2 | 0.9 | 2.9 | 0.6 | 2.6 | 0.7 | |
| chol (mmol L−1) | 7.2 | 0.9 | 7.1 | 0.5 | 7.1 | 0.9 | |
| GH (ng ml−1) | 13.84 | 8.88 | 10.59 | 6.85 | 6.23 | 2.92 | |
| IGF1 (ng ml−1) | 27.43 | 3.75 | 26.65 | 4.85 | 24.26 | 11.70 | |
| IGF1/GH | 1.74 | 0.56 | 3.71 | 2.43 | 4.21 | 3.53 |
Parameters (average AVG ± SD) in fish after conditioning for 8 months at minimal flow (C) and when induced to swim at 1 and 2 body length (BL) s−1. The first group of parameters (I) was monitored on a sample size of N = 40 fish per treatment group, the second group (II) on only the first N = 10 fish per treatment group. Significant differences (p < 0.05) are indicated in bold. For parameter abbreviations see text. a, b, c indicate what is similar and different from each other.
Figure 2Cortisol stress response. Shown are baseline cortisol levels, and levels 30 and 90 min after netting stress. Light gray: minimal flow. Dark gray: 1 BL s−1. Black: 2 BL s−1. The asterisk indicates overall significant difference at *p < 0.05: a lower baseline cortisol level of fish exercised at 1 BL s−1 vs. fish exercised at 2 BL s−1 and the controls.
Figure 3Differentially expressed genes (DEGs). Up- and down-regulated DEGs are shown in fish swimming at 1 BL s−1 (left) and 2 BL s−1 (right) vs. the controls with the overlap showing the common DEGs between both treatments.
Common differentially expressed genes (DEGs).
| Common DEGs | 1 BL s−1 vs. C | 2 BL s−1 vs. C |
|---|---|---|
| Kelch 41 | Inf | Inf |
| MHC class II antigen beta partial | 2.80 | 2.42 |
| DM-related transcriptional factor Dmrt2b | 2.52 | 2.83 |
| Angiopoietin-1 | 2.06 | 2.15 |
| Anoctamin-1-like isoform X2 | 0.56 | 0.55 |
| Cordon-bleu isoform X5 | 0.55 | 0.56 |
| Unconventional myosin-XVIIIa isoform X5 | 0.42 | 0.60 |
| MTSS1 isoform X1 | 0.40 | 0.38 |
| Transmembrane 145 | 0.13 | 0.14 |
| Sodium channel type 4 subunit alpha B-like isoform X2 | 0.06 | 0.40 |
Common genes for the muscle transcriptome comparisons of fish swimming at 1 body length (BL) per second (1 BL s−1) vs. controls, and 2 BL s−1 vs. controls. Data are shown as fold change between each treatment group versus the control group. “Inf” refers to significant expression in the treatment groups but zero expression in the control group.
Gene ontology of upregulated DEGs for flow conditioning at 1 BL s−1.
| fc | |
|---|---|
| NFX1-type zinc finger-containing 1 | 7.73 |
| Double sex- and mab-3-related transcription factor 2 | 5.39 |
| Zinc finger 804A | 4.32 |
| DNA-binding inhibitor ID-2 | 3.67 |
| Pro-cathepsin H | 2.88 |
| 5-AMP-activated kinase subunit gamma-1-like | 2.61 |
| Fibrinogen alpha chain | 17.51 |
| C-C chemokine receptor type 7 | 13.96 |
| Interferon regulatory factor 9 | 8.14 |
| rab5 GDP GTP exchange factor-like | 3.94 |
| Pro-cathepsin H | 2.88 |
| ras-related C3 botulinum toxin substrate 2 | 2.65 |
| HLA class II histocompatibility antigen gamma chain | 1.83 |
| Troponin skeletal muscle | 3.53 |
| Prostaglandin F synthase-like | 2.75 |
| 5-AMP-activated kinase subunit gamma-1-like | 2.61 |
| Myosin heavy partial | 2.28 |
| Myosin regulatory light chain skeletal muscle isoform-like | 1.91 |
Data are shown as fold change between each treatment group vs. the control group.
Gene ontology of up-regulated DEGs for flow conditioning at 2 BL s−1.
| fc | |
|---|---|
| Histone H2B | 9.29 |
| RNA polymerase II subunit A C-terminal domain phosphatase isoform X1 | 3.53 |
| zinc finger and SCAN domain-containing 22-like isoform X1 | 2.77 |
| Dual specificity phosphatase 22-A-like | 1.82 |
| HEXIM-like | 1.80 |
| Polyubiquitin-B | 1.75 |
| Caspase-8-like | 7.86 |
| Granzyme B-like | 4.00 |
| N-acetylated-alpha-linked acidic dipeptidase | 3.38 |
| MHC class I partial | Inf |
| Calsequestrin-2-like | 2.94 |
| Collagen alpha-1(XI) chain-like isoform X1 | 2.13 |
| Hyaluronan and proteoglycan link 1 | 1.64 |
| Extracellular calcium-sensing receptor-like | Inf |
Data are shown as fold change between each treatment group vs. the control group. “Inf” refers to significant expression in the treatment groups but zero expression in the control group.